New cancer clinical trial: Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

Published on: February 01, 2019 at 12:00PM
Conditions:   Castration-Sensitive Prostate Carcinoma;   Metastatic Prostatic Adenocarcinoma;   Stage IV Prostate Cancer;   Stage IVA Prostate Cancer;   Stage IVB Prostate Cancer
Interventions:   Drug: Abiraterone Acetate;   Drug: Antiandrogen Therapy;   Drug: Docetaxel;   Drug: Prednisone;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
Sponsor:   University of Utah
Not yet recruiting
http://bit.ly/2Bf3oAK